izvor podataka: crosbi
✓
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients. (CROSBI ID 97827)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Ahel, Zaky ; Kovačić, Ksenija ; Kraljić, Ivo ; Tarle, Marko.
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients. // Anticancer Research, 21 (2001), 1475-1480-x
Podaci o odgovornosti
Ahel, Zaky ; Kovačić, Ksenija ; Kraljić, Ivo ; Tarle, Marko.
engleski
Oral Estramustine therapy in serum Chromogranin A-positive Stage D3 prostate cancer patients.
Forty four pts with stage D3 prostate cancer were treated with estramustine during 15 months period. Monitoring included CgA value, TPSA level and bone scan data. Average response period evaluated by CgA decrease and inprovenent in bone scan data was 8.7 months.
prostate cancer; estramustine; chromogranin A
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Povezane osobe
Povezane ustanove
